11th week of 2012 patent applcation highlights part 38 |
Patent application number | Title | Published |
20120063953 | MEDICAL HEAT EXCHANGER, MANUFACTORING THEREOF AND ARTIFICIAL LUNG DEVICE - A thin tube bundle ( | 2012-03-15 |
20120063954 | ADSORBENTS FOR THE ADSORPTION OF HEPCIDIN - The invention relates to a device and a method for depletion of hepcidin from blood for treatment of iron deficiency, in particular in anemic patients suffering from chronic renal failure, with the goal of increasing the availability of iron in the body and thus improving the treatment of the anemia. The hepcidin adsorbent comprises a matrix and a hepcidin-binding ligand covalently bonded to the matrix with an affinity having a dissociation constant KD of less than 200 nM. | 2012-03-15 |
20120063955 | METAL-ENHANCED FLUORESCENCE FROM PLASTIC SUBSTRATES - The present invention relates to methods for functionally modifying a polymeric surface for subsequent deposition of metallic particles and/or films, wherein the polymeric surface is modified by increasing hydroxyl and/or amine functional groups thereby providing an activated polymeric surface for deposition of metallic particles to form a fluorescence sensing device. The device can be used for metal-enhanced fluorescence of fluorophores positioned above the metallic particles that can be readily applied to diagnostic or sensing applications of metal-enhanced fluorescence. | 2012-03-15 |
20120063956 | System for Visual and Electronic Reading of Colorimetric Tubes - Gas detector tubes may be used to determine a concentration of target gases in air. The gas detector tubes described may be read either by and optical reader or visually by the user. A gas detector tube reader having an optical reader capable of reading a length of stain, a color change and color density of a reagent in a gas detector tube. The gas detector tube may further comprise sensors for measuring the environmental conditions during sampling. | 2012-03-15 |
20120063957 | SYSTEM FOR PRESSURIZING FEEDSTOCK FOR FIXED BED REACTOR - In accordance with one embodiment, a system includes a posimetric pump configured to increase pressure of a feedstock to provide a pressurized feedstock. The system also includes a fixed bed gasifier configured to gasify the pressurized feedstock, wherein the fixed bed gasifier comprises an enclosure, a feedstock inlet configured to receive the pressurized feedstock, at least one agent inlet configured to receive at least one gasification agent, a syngas outlet configured to output a syngas, an ash outlet configured to output ash, and a fixed bed configured to support the pressurized feedstock while allowing flow of the at least one gasification agent through the pressurized feedstock. | 2012-03-15 |
20120063958 | MEDIA FOR PHOTOCATALYTIC FILTER - The invention relates to a filtering media having a photocatalytic action which has a thickness of at least 2 mm, which is homogeneous and which is devoid of orifice apparent to the naked eye, comprising a felt of inorganic fibers, the fibers of which are coated with a coating comprising a catalyst having a photocatalytic action, said felt exhibiting a weight per unit area of between 30 and 80 g/m | 2012-03-15 |
20120063959 | Reactor clamp and apparatus for sanitizing air and spaces including reactor clamp - An apparatus for sanitizing air includes a reactor, for generating reactive oxygen species from oxygen in air received in the reactor to be sanitized. The reactor includes at least one reaction chamber. The apparatus further includes a reactor clamp configured to support the at least one reaction chamber. | 2012-03-15 |
20120063960 | CLEANING COMPOUND FOR CLEANING SURFACES IN A FOOD PROCESSING ENVIRONMENT - A cleaning compound for cleaning surfaces in a food processing environment includes at least one container, with each container including a peroxide and/or an alkaline reactant therein. The alkaline reactant is selected to raise the pH of the cleaning compound into the alkaline range when the peroxide and the alkaline reactant are mixed together. The cleaning compound may be a liquid or dry compound, which is applied to the surface to be cleaned. | 2012-03-15 |
20120063961 | FLUID INJECTION NOZZLE FOR FLUID BED REACTORS - The liquid feed nozzle assemblies for a circulating fluid bed reactor comprise (i) a throttle body premixer to combine liquid feed with atomization steam upstream of a nozzle body to form a liquid feed/steam mixture comprising liquid feed droplets; (ii) a conduit connected to the venturi premixer and to a discharge nozzle body to convey a flow of the liquid/steam mixture created by the premixer to the nozzle body; (iii) a discharge nozzle connected to the flow conduit to shear the liquid feed/steam mixture to create liquid feed droplets of reduced size and (iv) a disperser at the outlet of the discharge nozzle to provide a spray jet of liquid feed having an increased surface area relative to a cylindrical jet. The nozzle assembles are particularly useful in fluid coking units using heavy oil feeds such a tar sands bitumen. | 2012-03-15 |
20120063962 | METHOD FOR PURIFYING FLUE GASES FROM COMBUSTION PLANTS AND THEN PRODUCING UREA - A method and apparatus is provided for cleaning flue gases from combustion plants. The method includes removing dust and removing nitrogen from flue gases, bringing flue gases into contact with an aqueous ammonia solution in the presence of an oxidizing agent whereby a reaction solution forms which contains at least ammonium carbonate, heating the reaction solution such that ammonium carbonate decomposes and carbon dioxide and ammonia transfer into the gas atmosphere, and reacting the gaseous carbon dioxide and the gaseous ammonia to form urea. The apparatus includes a device for removing nitrogen and removing dust from the flue gases, a washing device downstream of the device for removing nitrogen and removing dust, a stripper downstream of the washing device, and a urea installation downstream of the stripper. | 2012-03-15 |
20120063963 | SELECTIVE CO METHANATION CATALYST, METHOD OF PRODUCING THE SAME, AND APPARATUS USING THE SAME - Provided is a new catalyst capable of removing carbon monoxide economically without adding particular reaction gas externally. Also provided are a process for producing and an apparatus using such a catalyst. Impregnation of a Ni—Al composite oxide precursor of a nonstoichiometric composition prepared by the solution-spray plasma technique with a ruthenium salt to be supported and performing reduction treatment allows CO methanation reaction to selectively proceed even in the high-temperature range in which CO | 2012-03-15 |
20120063964 | APPARATUS FOR PRODUCING U3O8 POWDER - In an apparatus for producing U | 2012-03-15 |
20120063965 | METHOD AND APPARATUS FOR FAST PYROLYSIS OF BIOMASS IN ROTARY KILNS - Described herein are systems and methods for achieving fast pyrolysis of wood and other carbonaceous solids in rotary reactors. Novel heating, feeding and condensing methods result in high oil yields near those currently achieved with more complicated fast pyrolysis systems. High intensity burners are arranged and controlled to produce high heating rates and uniform temperature of the rotating cylindrical walls of the reactors. The feeding system delays the onset of pyrolysis until the solids fall onto the heated kiln walls. The pyrolysis gases and vapors are rapidly withdrawn and quenched with recycled liquids. The first condenser incorporates a clean out nozzle. Char products are readily separated and discharged into a heat exchanger where heat is recovered and used together with heat from reactor flue gas to dry the solids prior to being fed to the reactor. | 2012-03-15 |
20120063966 | Microplasma source and sterilization system including the same - A microplasma source and a sterilization system including the same are disclosed. The microplasma source includes: a microplasma-generating unit including: a gas transmission chamber having a first inlet and a first outlet wherein the first inlet is used to import a first gas; a protection and heat dissipation chamber of which a side is connected to the inner wall of the first outlet; a dielectric inner tube having a second inlet and a second outlet and penetrating through the protection and heat dissipation chamber, wherein the second inlet is communicated to the gas transmission chamber; an electrode arranged outside at the second outlet and located in the protection and heat dissipation chamber; and a hollow metal tube disposed in the gas transmission chamber and the dielectric inner tube and having a third inlet and a third outlet, wherein the third inlet is used to import a second gas. | 2012-03-15 |
20120063967 | HYDROGEN GENERATION SYSTEM AND HOT WATER PRODUCTION SYSTEM - A hydrogen generation system ( | 2012-03-15 |
20120063968 | APPARATUS FOR MANUFACTURING LARGE-AREA CARBON NANOTUBE FILMS - An apparatus for manufacturing a large-area carbon nanotube film includes a reactor chamber, a helical-shaped substrate, and a supporter. The reactor chamber includes an inlet and an outlet. The inlet and the outlet are aligned on an axis of the reactor chamber. The helical-shaped substrate and the supporter are located wholly inside the reactor chamber. The supporter is moveable along the axis of the reactor chamber, and the helical-shaped substrate is supported by the supporter. | 2012-03-15 |
20120063969 | BIOPOLYMER EXTRACTION FROM PLANT MATERIALS - Disclosed is a method and apparatus for the extraction of high molecular weight biopolymers from plants. Specifically, invention described herein relates to the commercial processing of plant material, including that from desert plants native to the southwestern United States and Mexico, such as the guayule plant ( | 2012-03-15 |
20120063970 | METHOD FOR PRODUCING AN ANALYTICAL MAGAZINE - A method for producing an analytical magazine is proposed. The analytical magazine is designed to receive a plurality of analytical aids in a plurality of chambers. The method comprises the following steps: providing at least one first component of the analytical magazine, wherein the first component comprises a plurality of receptacles; providing a plurality of analytical aids, wherein the analytical aids are connected to one another and preferably oriented with respect to one another by at least one holding element; introducing the analytical aids into the receptacles; and separating the analytical aids from the holding element. | 2012-03-15 |
20120063971 | INERTIAL PARTICLE FOCUSING SYSTEM - An inertial particle focusing system for use with a particle having diameter (a) includes a curved microchannel into a substrate, said microchannel having a radius of curvature (r), and a channel hydraulic diameter (D | 2012-03-15 |
20120063972 | DEVICE HAVING REGIONS OF DIFFERING AFFINITIES TO FLUID, METHODS OF MAKING SUCH DEVICES, AND METHODS OF USING SUCH DEVICES - A microfluidic device comprising a first surface portion and a first sample retaining element, which have differing affinities to a fluid, and a method comprising supplying a sample to such a device. In some embodiments, the differing affinity is a result of plasma, ion embedding, surface charging, chemical, optical, electronic and/or electromagnetic treatment. Also, a microfluidic device comprising at least one microcapillary device having a sample retaining element, at least one surface of which exhibits hydrophobicity, hydrophilicity, electromagnetic force exertion and electrostatic force exertion. Also, a microfluidic device comprising a first element having a hydrophilic pattern comprising at least a first sample retaining element. Also, a method comprising supplying a sample to a channel between a first element and a second element, and inducing in the first element at least one hydrophilic pattern by electrets or by internal or external electrodes to provide a charged surface. | 2012-03-15 |
20120063973 | Flexible Fluid Storage and Warming Bag and a Fluid Storage and Warming System - In an embodiment, a flexible fluid storage and warming bag may be provided. The flexible fluid storage and warming bag may include two flexible main walls, each including a surrounding edge, the two flexible main walls overlapping each other and being fluid-tightly sealed together along the surrounding edges thereof, the bag including a single non-partitioned fluid chamber defined by and between the two flexible main walls and by the sealed surrounding edges; at least one fluid transfer port extending into the single non-partitioned fluid chamber and being configured to allow transfer of the fluid into and out of the bag; and an electrical heating element integrated with at least one of the two flexible main walls of the bag. A fluid storage and warming system may also be provided. | 2012-03-15 |
20120063974 | Method of Beneficiating and Drying Trona Ore Useful for Flue Gas Desulfurization - A method of producing trona suitable for flue gas desulfurization comprising mechanically mining a trona ore deposit containing insoluble impurities; crushing the mined trona ore to create a mixture of uncalcined trona-rich particles and impurities-rich particles; beneficiating the crushed uncalcined trona ore to obtain a trona-rich, impurities-depleted ore fraction; and drying the trona-rich ore fraction under non-calcining conditions to yield a dry uncalcined trona ore. A preferred embodiment includes concurrently milling and drying the trona-rich, impurities-depleted ore fraction to recover a low moisture content trona product having a high NaHCO | 2012-03-15 |
20120063975 | PROCESS GAS TREATMENT SYSTEM - A system is arranged to remove carbon dioxide (CO2) from a gas stream by bringing the gas stream into contact with a circulating ammoniated solution stream such that CO2 is removed from the gas stream by the ammoniated solution stream. A method of removing non-volatile compounds from the circulating ammoniated solution stream includes: introducing a portion of the circulating ammoniated solution stream into a gas-liquid separating device; and separating the introduced ammoniated solution into an ammonia rich gas phase and a liquid phase comprising the non-volatile compounds; and reintroducing the ammonia rich gas phase into the circulating ammoniated solution stream. | 2012-03-15 |
20120063976 | METHODS OF REMOVING CARBON DIOXIDE AND SORBENTS FOR SAME - Methods of removing carbon dioxide comprising contacting a gas mixture comprising carbon dioxide with a sorbent. The sorbent comprises the following chemical structure: | 2012-03-15 |
20120063977 | IONIC LIQUIDS FOR REMOVAL OF CARBON DIOXIDE - Ionic liquids containing a cation with a potentially nucleophilic carbon atom bearing a relatively acidic hydrogen atom bonded to a potentially nucleophilic carbon atom, typically in the conjugated —NC(H)N— structure or a —NC(H)S— structure of imidazolium, imidazolidinium or thiazolium salts, can be capable of acting as sorbents for CO | 2012-03-15 |
20120063978 | IONIC LIQUIDS AS AMINE PROMOTER SOLVENTS FOR REMOVAL OF CARBON DIOXIDE - Ionic liquids are capable of acting as solvents for amine CO | 2012-03-15 |
20120063979 | High CO2 to Amine Adsorption Capacity CO2 Scrubbing Processes | 2012-03-15 |
20120063980 | Alkanolamine CO2 Scrubbing Process | 2012-03-15 |
20120063981 | METHOD AND APPARATUS FOR REMOVING CONTAMINANT FROM FLUID - Methods, apparatus, and systems for removing contaminant in a fluid (e.g., chemical and petrochemical gas streams) using nanostructures of a sorbent material coated on plates such as a silicon wafer. A plurality of such coated plates can be assembled to form a sorption structure having channels between the plates. When a fluid containing the contaminant is directed through the channels, the contaminant is adsorbed by the nanostructures of the sorbent material. | 2012-03-15 |
20120063982 | PROCESS AND DEVICE FOR DECOMPOSING LAUGHING GAS - The laughing-gas-containing gas ( | 2012-03-15 |
20120063983 | Method for Synthesis of Boron Nitride Nanopowder - A reaction is carried in a gaseous phase between ammonia (NH | 2012-03-15 |
20120063984 | PROCESSES AND AN APPARATUS FOR MANUFACTURING HIGH PURITY POLYSILICON - In one embodiment, the instant invention includes a method having steps of: feeding a fluidizing gas stream having at least 80 percent of halogenated silicon source gas or mixture of halogenated silicon source gases to fluidize silicon seeds in a reactor, achieving the fluidization of silicon seeds in a reaction zone prior to when the fluidizing gas stream reaches at least 600 degrees Celsius; heating the fluidized silicon seeds residing within the reaction zone to a sufficient reaction temperature to result in more than 50% of the equilibrium conversion for the thermal decomposition reaction in the reaction zone of the reactor; and maintaining the fluidizing gas stream at the sufficient reaction temperature and a sufficient residence time within the reaction zone hereby resulting in more than 50% of the equilibrium conversion for the thermal decomposition reaction in a single stage within the reaction zone to produce an elemental silicon. | 2012-03-15 |
20120063985 | SILICON MANUFACTURING APPARATUS AND SILICON MANUFACTURING METHOD - In a silicon manufacturing apparatus and its related manufacturing method, a zinc gas supply opening ( | 2012-03-15 |
20120063986 | NITRIDE SEMICONDUCTOR LASER DEVICE - A nitride semiconductor laser device includes an n-type AlGaN clad layer, a GaN layer, a first InGaN light guide layer, a light-emitting layer, a second InGaN light guide layer, a nitride semiconductor inter mediate layer, a p-type AlGaN layer, and a p-type AlGaN clad layer stacked in this order on a nitride semiconductor substrate, wherein the n-type AlGaN clad layer has an Al composition ratio of 3-5% and a thickness of 1.8-2.5 μm; the first and second InGaN light guide layers have an In composition ratio of 3-6%; the first light guide layer has a thickness of 120-160 nm and greater than that of the second light guide layer; and the p-type AlGaN layer is in contact with the p-type clad layer and has an Al composition ratio of 10-35% and greater than that of the p-type clad layer. | 2012-03-15 |
20120063987 | GROUP-III NITRIDE CRYSTAL AMMONOTHERMALLY GROWN USING AN INITIALLY OFF-ORIENTED NON-POLAR OR SEMI-POLAR GROWTH SURFACE OF A GROUP-III NITRIDE SEED CRYSTAL - A method for ammonothermally growing group-III nitride crystals using an initially off-oriented non-polar and/or semi-polar growth surface on a group-III nitride seed crystal. Group-III-containing source materials and group-III nitride seed crystals are placed into a vessel, wherein the seed crystals have one or more non-polar or semi-polar growth surfaces. Group-III nitride crystals are ammonothermally grown by filling the vessel with a nitrogen-containing solvent for dissolving the source materials and transporting a fluid comprised of the solvent with the dissolved source materials to the seed crystals for growth of the group-III nitride crystals on the seed crystals. The growth surfaces are initially off-oriented growth surfaces, wherein the growth surfaces are off-oriented m-plane or highly vicinal m-plane growth surfaces. The growth surfaces of the seed crystals may be created by cutting group-III nitride crystals at a desired angle with respect to an m-plane. | 2012-03-15 |
20120063988 | Dissolution Of Graphite, Graphite And Graphene Nanoribbons In Superacid Solutions And Manipulation Thereof - Methods for dissolving carbon materials such as, for example, graphite, graphite oxide, oxidized graphene nanoribbons and reduced graphene nanoribbons in a solvent containing at least one superacid are described herein. Both isotropic and liquid crystalline solutions can be produced, depending on the concentration of the carbon material The superacid solutions can be formed into articles such as, for example, fibers and films, mixed with other materials such as, for example, polymers, or used for functionalization of the carbon material. The superacid results in exfoliation of the carbon material to produce individual particles of the carbon material. In some embodiments, graphite or graphite oxide is dissolved in a solvent containing at least one superacid to form graphene or graphene oxide, which can be subsequently isolated. In some embodiments, liquid crystalline solutions of oxidized graphene nanoribbons in water are also described. | 2012-03-15 |
20120063989 | HIGHLY ACTIVE SHIFT CATALYSTS - The present invention relates to a highly active water gas shift catalyst and a process for producing it, and also a process for converting a gas mixture comprising at least carbon monoxide and water into hydrogen and carbon dioxide in a wide temperature range using this catalyst. | 2012-03-15 |
20120063990 | METHOD FOR FORMING GRANULAR POLYNARY NANO COMPOUND - The invention discloses a method for forming granular polynary nano compound, which comprises the steps of (S | 2012-03-15 |
20120063991 | METHOD OF TREATING AN ACID GAS STREAM AND AN APPARATUS THEREFOR - The present invention provides a method of treating an acid gas stream ( | 2012-03-15 |
20120063992 | PROCESS FOR THE PRODUCTION OF NANOPARTICLES USING MINIEMULSIONS - The present invention relates to a process for the production of nanoparticles or nanostructured particles with the help of a 2-emulsion method, particles being produced through targeted coalescence of miniemulsions in a high-pressure homogenized. | 2012-03-15 |
20120063993 | THERAPEUTIC AND DIAGNOSTIC CONJUGATES FOR USE WITH MULTISPECIFIC ANTIBODIES - Disclosed are compounds that include two or more haptens conjugated by a spacer or a carrier. The haptens may include diethylenetriaminepentaacetate (DTPA), histimine-succinyl-glutamine (HSG), or combinations of DTPA and HSG. The compound also includes an effector molecule which may be conjugated to one or more of the haptens, the spacer/carrier, or both. The effector molecule may be conjugated by a number of linkages including an ester linkage, an imino linkage, an amino linkage, a sulfide linkage, a thiosemicarbazone linkage, a semicarbazone linkage, an oxime linkage, an ether linkage, or combinations of these linkages. Also disclosed are methods of synthesizing the compounds and/or precursors of the compounds. | 2012-03-15 |
20120063994 | RTEF-1 VARIANTS AND USES THEREOF - Disclosed are variant RTEF-1 polypeptides having an RTEF-1 amino acid sequence with one or more internal deletions, wherein the polypeptides reduce VEGF promoter activity. Some of the RTEF-1 polypeptides include an amino acid sequence that is at least 80% identical to the contiguous amino acids of 1) amino acids 24 to 47 of SEQ ID NO:15 and 2) each of SEQ ID NOs:16 and 17, but does not comprise the contiguous amino acids of SEQ ID NOs:8, 9, 11, or 12. Also disclosed are nucleic acids encoding the variant RTEF-1 polypeptides of the present invention. Pharmaceutical compositions that include the polypeptides and nucleic acids of the present invention are also disclosed. Methods of inducing cell contact inhibition, regulating organ size, and reducing intracellular YAP activity are also set forth, as well as methods of treating hyperproliferative diseases such as cancer using the pharmaceutical compositions of the present invention. | 2012-03-15 |
20120063995 | NON-AD5 ADENOVIRAL VECTORS AND METHODS AND USES RELATED THERETO - Oncolytic human adenoviral vectors and cells and pharmaceutical compositions including the vectors. Also provided are methods for using the vectors in the manufacture of a medicament for treating cancer in a subject and a method of treating cancer in a subject. Furthermore, methods of producing an adenoviral vector are provided. | 2012-03-15 |
20120063996 | NOVEL NIMESULIDE COMPOSITIONS - The present invention provides nanoparticulate nimesulide compositions. The compositions preferably comprise nimesulide and at least one surface stabilizer adsorbed on or associated with the surface of the nimesulide particles. The nanoparticulate nimesulide particles preferably have an effective average particle size of less than about 2000 nm. The invention also provides methods of making and using nanoparticulate nimesulide compositions. | 2012-03-15 |
20120063997 | DELIVERY SYSTEM WITH SCAFFOLDS - An injectable, agent delivery system comprising a composition comprising: (i) an injectable scaffold material comprising discrete particles, which are capable of interacting to form a scaffold; and (ii) a carrier comprising an agent for delivery. The product can have a pharmaceutical use or use in cosmetic surgery; in particular it can be used in tissue regeneration or reconstruction. The agent for delivery may be a therapeutically, prophylactically or diagnostically active substance. | 2012-03-15 |
20120063998 | Method for Treating Psoriatic Arthritis by Administering an Anti-IL-12 Antibody - Isolated anti-IL-12 antibodies, nucleic acids encoding antibodies or antibody portions, vectors, host cells, and methods of making are useful for production of antibody or portions for treating and/or diagnosing IL-12 related conditions, diseases, and disorders, such as psoriatic arthritis. | 2012-03-15 |
20120063999 | PSCA: PROSTATE STEM CELL ANTIGEN AND USES THEREOF - The invention provides a novel prostate cell-surface antigen, designated Prostate Stem Cell Antigen (PSCA), which is widely over-expressed across all stages of prostate cancer, including high grade prostatic intraepithelial neoplasia (PIN), androgen-dependent and androgen-independent prostate tumors. | 2012-03-15 |
20120064000 | Human Monoclonal Antibodies Against Hendra And Nipah Viruses - The present invention relates to monoclonal antibodies that bind or neutralize Hendra or Nipah virus. The invention provides such antibodies, fragments of such antibodies retaining Hendra or Nipah virus-binding ability, fully human antibodies retaining Hendra or Nipah virus-binding ability, and pharmaceutical compositions including such antibodies. The invention further provides for isolated nucleic acids encoding the antibodies of the invention and host cells transformed therewith. Additionally, the invention provides for prophylactic, therapeutic, and diagnostic methods employing the antibodies and nucleic acids of the invention. | 2012-03-15 |
20120064001 | Anti-VEGF Antibody Compositions and Methods - Disclosed are human antibodies that specifically inhibit VEGF binding to only one (VEGFR2) of the two primary VEGF receptors. The antibodies effectively inhibit angiogenesis and induce tumor regression, and yet have improved safety due to their specificity. The present invention thus provides new human antibody-based compositions, methods and combined protocols for treating cancer and other angiogenic diseases. Advantageous immunoconjugate compositions and methods using the new VEGF-specific human antibodies are also provided. | 2012-03-15 |
20120064002 | Enantiomer-pure (4S,8S)- and (4R,8R)-4-p-Nitrobenzyl-8-methyl-3,6,9-triaza-3N,6N,9N-tricarboxymethyl-1- ,11-undecanedioic Acid and Derivatives Thereof, Process for their Production and Use for the Production of Pharmaceutical Agents - Enantiomer-pure compounds of general formulas VIIa and VIIb | 2012-03-15 |
20120064003 | COMPLEX FOLATE-NOTA-Ga68 - The present invention concerns a Ga68 complex of formula FOLATE-(LINKER)i-NOTA-Ga | 2012-03-15 |
20120064004 | ISOTOPOLOGUES OF THALIDOMIDE - Provided herein are thalidomide, which is enriched with isotopes such as deuterium. Pharmaceutical compositions comprising the isotopes-enriched compounds, and methods of using such compounds are also provided. | 2012-03-15 |
20120064005 | RADIOLABELED PDE10 INHIBITORS - The present invention is directed to radiolabeled pyrimidinone compounds of general structural formula I which are useful as radiotracers for quantitative imaging of PDE10 in mammals. | 2012-03-15 |
20120064006 | SYSTEMS AND METHODS FOR USING PHYSIOLOGICAL INFORMATION - Systems and methods using a database of physiological information for the design, development, testing and use of therapeutics. In one aspect, the physiological information can include at least one of: hemodynamic monitoring information, pulmonary arterial pressure, cardiac output, heart rate, respiratory rate, peripheral vascular resistance, total peripheral resistance or dicrotic notch information. Optionally, the cardiovascular physiology information can include ambulatory physiological information. | 2012-03-15 |
20120064007 | METHODS OF USING SUSTAINED RELEASE AMINOPYRIDINE COMPOSITIONS - A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition. | 2012-03-15 |
20120064008 | COMPOSITIONS FOR THE TREATMENT OF METASTATIC CANCER AND METHODS OF USE THEREOF - An in vivo assay for assessing the metastatic potential of cancer cells has been developed. This is a functional assay that also allows for screening of compounds that are selective for metastatic cancer. Metastatic cancer is established in animals by intravenous injection of metastatic cancer cells before treatments are tested. This assay has been used to identify benzimidazoles for the treatment of metastatic prostate cancers. The benzimidazole(s) can be formulated for enteral or parenteral administration. In one embodiment, the compositions are formulated for parenteral administration. Compositions containing a benzimidazole exhibit greater cytotoxicity against cell lines prone to metastasis than against cells lines that are less prone to metastasis in vitro. The benzimidazoles described herein were effective at treating metastatic prostate cancer in bone. Administration of benzimidazoles in metastatic prostate cancer mouse models showed a significant increase in the survival times of the animals, even against paclitaxel resistant cancer cell lines. | 2012-03-15 |
20120064009 | METHODS OF LEUKEMIA CELL DETECTION - Methods are provided for, inter alia, determining the presence of leukemia cells in a subject, determining the change or potential change in the number of leukemia cells in the subject with time, determining whether a tissue in a subject contains a plurality of leukemia cells or a plurality progenitor leukemia cells, and determining whether a leukemia therapy administered to a subject is capable of decreasing the number of leukemia cells in a tissue of the subject. | 2012-03-15 |
20120064010 | CCR3 and its Ligands Are Therapeutic and Diagnostic Targets for Neovascular Age-Related Macular Degeneration - The results presented herein demonstrate the specific expression of CCR3 in CNV endothelial cells in humans with AMD, and despite the expression of its ligands, eotaxin-1, -2, and -3, neither eosinophils nor mast cells are present in human CNV. The genetic or pharmacological targeting of CCR3 or eotaxins as disclosed herein inhibited injury-induced CNV in mice. CNV suppression by CCR3 blockade was due to direct inhibition of endothelial cell proliferation, and was uncoupled from inflammation as it occurred in mice lacking eosinophils or mast cells and was independent of macrophage and neutrophil recruitment. CCR3 blockade was more effective at reducing CNV than vascular endothelial growth factor-A (VEGF-A) neutralization, which is currently in clinical use, and, unlike VEGF-A blockade, not toxic to the mouse retina. In vivo imaging with CCR3-targeting quantum dots located spontaneous CNV invisible to standard fluorescein angiography in mice before retinal invasion. CCR3 targeting is useful in reducing vision loss due to AMD through early detection and therapeutic angioinhibition. | 2012-03-15 |
20120064011 | PREPARATION FOR EXTERNAL APPLICATION - Preparations for external application to human and animal skin, comprising: a) a composition in the form of a fluid nanophase system, comprising the components of a1) at least one water-insoluble substance with a water solubility of less than 4 gram per liter, a2) at least one amphiphilic substance (NP-MCA), which has no surfactant structure, does not build structures alone, the solubility of which is between 4 g and 1000 g per liter in water or oil and which does not enrich preferably at the oil-water interface, a3) at least one anionic, cationic, amphoteric and/or non-ionic surfactant, a4) at least one polar protic solvent, in particular having hydroxy functionality, a5) if necessary one or more adjuvants, wherein the percentage relate to the total weight of the composition each; and b) a therapeutic, cosmetic or diagnostically effective agent in a therapeutic, cosmetic or diagnostically effective amount. | 2012-03-15 |
20120064012 | Uniform Fluorescent Microspheres with Hydrophobic Surfaces - Fluorescent microspheres for the measurement of blood flow are provided. The microspheres are substantially uniform in diameter and have a hydrophobic surface, which allows them to circulate more freely throughout bloodstream, while reducing immunogenicity, particle aggregation and bioaccumulation. The hydrophobic surface on each microsphere is generally comprised of polymeric material having a limited surface charge. | 2012-03-15 |
20120064013 | FOAMABLE TOPICAL COMPOSITION - A foamable composition for topical application, the composition comprising a water in oil emulsion which is devoid of gelling agents. | 2012-03-15 |
20120064014 | AZEOTROPE-LIKE COMPOSITIONS COMPRISING 1-CHLORO-3,3,3-TRIFLUOROPROPENE - An azeotrope-like mixture consisting essentially of chlorotrifluoropropene and at least one component selected from the group consisting of a C | 2012-03-15 |
20120064015 | Food Additive Composition as an Agent for Reducing the Adhesion of Dental Biofilms in Sweetened Products - The present invention relates to a food additive composition to be added to sugar or sweetened products containing cariogenic free sugars or by-products thereof, enabling a reduction of the adhesion of dental biofilms and the appearance of caries while strengthening the tooth and the dental support tissue. The present invention also relates to food products made of cariogenic free sugars or by-products thereof containing said food additive product, as well as to a method of manufacturing such a food product containing said food additive composition, such as a chocolate. | 2012-03-15 |
20120064016 | ACTIVE GASES AND TREATMENT METHODS - A method of making an active gas by generating a glow discharge, non-thermal plasma, in a gas mixture of a carrier gas and a more readily ionisable gas. The gas mixture is exposed to water vapour at or downstream from the generator to form the active gas. The gas mixture includes helium as the carrier gas and up to 40% by volume of at least one noble gas such as argon, krypton, or xenon as the more readily ionisable gas. The gas mixture is ejected at a temperature between 5° C. to 42° C. The active gas may be used for oral treatment such as cosmetic whitening of teeth, medical or non-clinical cleaning of teeth or for cleaning laundry or dishwashing items. | 2012-03-15 |
20120064017 | BORINIC COMPOSITIONS - A stabilized oral care composition comprising a borinic acid derivative, e.g., a borinic ester. | 2012-03-15 |
20120064018 | AQUEOUS COPOLYMER DISPERSION OF POLYSILOXANE/POLYUREA, COSMETIC COMPOSITION COMPRISING THE SAME, METHOD FOR COSMETIC TREATMENT AND METHOD FOR PREPARATION - The invention relates to an aqueous dispersion of polysiloxane/polyurea copolymer and a method for preparation thereof comprising the steps: solubilisation of the copolymer and silane in an organic phase, preparation of an aqueous phase comprising one or more surfactants, mixing the organic and aqueous phase followed by emulsification. The invention further relates to a cosmetic composition comprising said dispersion and a cosmetic treatment using said composition. | 2012-03-15 |
20120064019 | COSMETIC COMPOSITION FOR MAKING-UP AND/OR CARING FOR KERATIN MATERIALS AND MAKE-UP METHOD - The invention relates to a composition containing the following components in a physiologically acceptable medium, namely: a) a siloxane resin comprising at least 80 mole % of units (i) (R3Si01/2)a and (ii) (SiO4/2)b, wherein R′ represents independently an alkyl group having between 1 and 8 carbon atoms, an aryl group, a carbinol group or an amino group (provided that at least 95 mole % of the R′ groups are alkyl groups), a and b have values strictly greater than 0 and the a/b ratio is between 0.5 and 1.5; b) a propyl silsesquioxane resin comprising at least 80 mole % of (R″SiO3/2) units, wherein R″ represents independently an alkyl group having between 1 and 8 carbon atoms, an aryl group, a carbinol group or an amino group, provided that at least 80 mole % of the R″ groups are propyl groups, whereby the weight ratio between resins (a) and (b) is between 1/99 and 99/1, in particular between 85/15 and 15/85, resins (a) and (b) are not linked by covalent bonds and the number of units M in the final mixture is strictly less than the number of units (T+Q); and c) at least one non-volatile oil, preferably a hydrocarbon oil and preferably selected from the group containing paraffin oil (or petroleum jelly), squalane, hydrogenated polyisobutene (Parleam oil), perhydrosqualene, mink oil, turtle oil, soybean oil, sweet almond oil, Calophyllum oil, palm oil, grapeseed oil, sesame oil, corn oil, arara oil, rapeseed oil, sunflower oil, cottonseed oil, apricot oil, castor oil, avocado oil, jojoba oil, olive oil or cereal germ oil; esters of lanolic acid, oleic acid, lauric acid, stearic acid; fatty esters, particularly at C12-C36, such as isopropyl myristate, isopropyl palmitate, butyl stearate, hexyl laurate, diisopropyl adipate, isononyl isononanoate, 2-ethyl-hexyl palmitate, 2-hexyl-decyl laurate, 2-octyl-decyl palmitate, 2-octyl-dodecyl lactate or myristate, di(2-ethyl hexyl) succinate, diisostearyl malate, glycerin or diglycerin triisostearate; behenic acid, oleic acid, linoleic acid, linolenic acid or isostearic acid; higher fatty alcohols, particularly at C16-C22, such as cetanol, oleic alcohol, linoleic or linolenic alcohol, octyl dodecanol or isostearic alcohol; and mixtures thereof. | 2012-03-15 |
20120064020 | NOVEL COMPOSITION - The present invention relates to a composition comprising N2-(1-oxohexadecyl)-lysyl-valyl-lysine or a salt thereof, spent grain wax and/or conjugated linoleic acid. The compositions are particularly useful for the treatment or co-treatment of rosacea and its symptoms. Furthermore the invention relates to a stable W/O emulsion pre-mix comprising the composition according to the invention. | 2012-03-15 |
20120064021 | DENDROBIUM CHYSOTOXUM EXTRACT AND ITS COSMETIC USE AS AN ANTI-AGING AGENT - The invention relates to a cosmetic composition comprising at least one extract from the orchid | 2012-03-15 |
20120064022 | CYCLOSILOXANE-SUBSTITUTED POLYSILOXANE COMPOUNDS, COMPOSITIONS CONTAINING THE COMPOUNDS AND METHODS OF USE THEREOF - Provided herein are cyclosiloxane-substituted polysiloxane compounds, compositions that include the polysiloxane compounds, and methods for preparation and use of the polysiloxane compounds. Provided are mechanical lubricant compositions, hydraulic fluid compositions, anti-foam compositions, water repellant agent compositions, release agent compositions, personal care compositions, cosmetic compositions, household care compositions and drug delivery compositions that include one or more of the cyclosiloxane-substituted polysiloxane compounds provided herein. | 2012-03-15 |
20120064023 | AGENTS FOR FIBERS CONTAINING KERATIN, CONTAINING AT LEAST ONE SPECIAL CROSS-LINKED AMPHIPHILIC, ANIONIC POLYMER AND AT LEAST ONE FURTHER SPECIAL NON-CROSS-LINKED AMPHIPHILIC ANIONIC POLYMER - Agents for treating fibers containing keratin containing in a cosmetically acceptable carrier (a) at least one cross-linked, amphiphilic, anionic polymer, comprising at least one structural unit of formula (I) and at least one structural unit of formula (II); and (b) at least one non-cross-linked, amphiphilic, anionic polymer, comprising at least one structural unit of the formula (III) and at least one structural unit of the formula (IV), said agents being suitable for temporarily deforming hair and for conditioning hair, in particular in the form of a hair cream or a hair gel. | 2012-03-15 |
20120064024 | Precipitated Polymers - The present invention relates to precipitation polymers which comprise, in copolymerized form, 80 to 99.9% by weight of at least one nonionic water-soluble monomer a) and 0.1 to 20% by weight of a monomer b) carrying amide or urea groups. The invention further relates to the use of these polymers as rheology modifiers for in particular aqueous compositions and as rheology-modifying setting agents in hair cosmetics. The invention further relates to aqueous compositions comprising these polymers. | 2012-03-15 |
20120064025 | Quinazolinone Modulators Of Nuclear Receptors - Compounds, pharmaceutical compositions and methods for modulating the activity of nuclear receptors are provided. In particular, quinazolinones are provided for modulating the activity of farnesoid X receptor (FXR) and/or orphan nuclear receptors. | 2012-03-15 |
20120064026 | METHOD FOR PREVENTING AND CONTROLLING BIOFOULING ON MARINE OBJECTS - A method for preventing and controlling the formation of biofouling on an object that is immersed or partially immersed in a water environment in which there is one or more organic or inorganic compounds capable of releasing gas, comprising the step of applying to the surface of the object a composition comprising a polymeric resin and one or more enzymes or a paint or a coating and one or more enzymes, wherein the one or more enzymes are adapted to catalyze a reaction of the one or more compounds that leads to the formation of gas. | 2012-03-15 |
20120064027 | Absorbable adhesive paste - An absorbable adhesive paste contains absorbable solid carboxy-bearing microparticles dispersed in a continuous phase of an alkoxyalkyl cyanoacrylate. The paste may contain a soluble absorbable polymeric viscosity modifier and at least one bioactive agent to maximize the effective application as a cover for compromised tissues and wounds or as sealants, blocking agents, or hemostatic agents. | 2012-03-15 |
20120064028 | Pregnancy-Induced Oligodendrocyte Precursor Cell Proliferation Regulated by Prolactin - The present invention relates to a method to increase oligodendrocytes and oligodendrocyte precursor cells through administration of prolactin or a prolactin inducing agent. | 2012-03-15 |
20120064029 | COMPOSITIONS FOR TREATING NERVOUS SYSTEM CONDITIONS - Compositions for treating nervous system conditions. In at least one embodiment of a stem cell conditioned medium of the present disclosure, the stem cell comprises a cell culture supernatant containing at least one factor capable of exerting effective neuroprotection to treat a mammalian neural injury or insult, the cell culture supernatant produced by culturing at least one mammalian adipose stem cell to produce the at least one factor. | 2012-03-15 |
20120064030 | METHODS OF TREATING NERVOUS SYSTEM CONDITIONS - Methods of treating nervous system conditions. In at least one embodiment of a method of treating a mammalian patient having a neuronal injury or insult of the present disclosure, the method comprises the step of administering a therapeutically-effective dose of a stem cell conditioned medium to a mammalian patient, the stem cell conditioned medium comprising a cell culture supernatant containing at least one factor capable of exerting effective neuroprotection to treat a mammalian neural injury or insult. | 2012-03-15 |
20120064031 | CELLS, NUCLEIC ACID CONSTRUCTS, CELLS COMPRISING SAID CONSTRUCTS AND METHODS UTILIZING SAID CELLS IN THE TREATMENT OF DISEASES - The present invention relates to cells capable of expressing IDO, nucleic acid constructs for expression of IDO, cells comprising said constructs and methods of utilizing said cells in the treatment of diseases. In particular the present invention relates to cells which expresses IDO in the absence of exposure to IFN-gamma, and to their use in preparation and/or generation of immunomodulatory cells specific for an antigen. | 2012-03-15 |
20120064032 | NOVEL HYDROXAMATES AS THERAPEUTIC AGENTS - The present invention is directed to certain hydroxamate derivatives that are useful in the treatment of hepatitis C. These compounds are also inhibitors of histone deacetylase and are therefore useful in the treatment of diseases associated with histone deacetylase activity. Pharmaceutical compositions and processes for preparing these compounds are also disclosed. | 2012-03-15 |
20120064033 | MODULATION OF REGULATORY T CELLS BY HUMAN IL-18 - The present invention relates to compositions and methods for modulating the presence and/or activity of regulatory T cells in a subject. | 2012-03-15 |
20120064034 | Peptidomimetic protease inhibitors - The present invention relates to peptidomimetic compounds useful as protease inhibitors, particularly as serine protease inhibitors and more particularly as hepatitis C NS3 protease inhibitors; intermediates thereto; their preparation including novel steroselective processes to intermediates. The invention is also directed to pharmaceutical compositions and to methods for using the compounds for inhibiting HCV protease or treating a patient suffering from an HCV infection or physiological condition related to the infection. Also provided are pharmaceutical combinations comprising, in addition to one or more HCV serine protease inhibitors, one or more interferons exhibiting anti-HCV activity and/or one or more compounds having anti HCV activity and a pharmaceutically acceptable carrier, and methods for treating or preventing a HCV infection in a patient using the compositions. The present invention is also directed to a kit or pharmaceutical pack for treating or preventing HCV infection in a patient. | 2012-03-15 |
20120064035 | VACCINE IMMUNOTHERAPY - A composition for treating cancer, including synergistic amounts of a primary cell-derived biologic having the cytokines IL-1, IL-2, IL-6, IL-8, TNF-α, and IFN-γ, and a cancer vaccine having at least one antigen. A composition comprising synergistic amounts of the primary cell-derived biologic in combination with at least one adjuvant. A method of treating cancer by administering the composition. A method of reversing immune suppression and gaining immunity to cancer. A method of producing an immune response to an exogenous antigen. A method of enhancing an immune response in a patient by administering the primary cell-derived biologic in combination with at least one adjuvant, and enhancing the immune response of the patient by a synergistic interaction of the primary cell-derived biologic and the adjuvant. A method of increasing function of an immune system. | 2012-03-15 |
20120064036 | Methods of Administration of Thrombopoietin Agonist Compounds - The embodiments provide methods of administering a high dose or a loading dose of a TPO modulator to a subject. The embodiments further provide methods of treating thrombocytopenia and/or neutropenia in a subject. Additionally, the embodiments further provide methods of increasing platelet production and/or enhancing the number of peripheral blood stem cells in a subject. | 2012-03-15 |
20120064037 | Methods For Treating Diseases and HCV Using Antibodies To Aminophospholipids - Disclosed are surprising discoveries concerning the role of anionic phospholipids and aminophospholipids in tumor vasculature and in viral entry and spread, and compositions and methods for utilizing these findings in the treatment of cancer and viral infections. Also disclosed are advantageous antibody, immunoconjugate and duramycin-based compositions and combinations that bind and inhibit anionic phospholipids and aminophospholipids, for use in the safe and effective treatment of cancer, viral infections and related diseases. | 2012-03-15 |
20120064038 | EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND METHODS OF USE IN ADENOVIRAL-ASSOCIATED VIRUS TYPE 6 (AAV6) TRANSDUCTION - Comparative gene analysis (CGA) was combined with pathway visualization software to identify a positive correlation between AAV6 transduction and epidermal growth factor receptor (EGFR) expression. It was found that EGFR is necessary for vector internalization and functions as a co-receptor for AAV6. The identification and characterization of AAV6's requirement of EGFR expression for high transduction activity has allowed construction of recombinant AAV6 vectors which are capable of targeting and killing specific types of head and neck tumors that because of this high EGFR activity, were until now, refractory to current therapies. | 2012-03-15 |
20120064039 | Use of Guanylyl Cyclase C Agonists to Suppress Appetite - Compositions comprising a guanylyl cyclase C agonist formulated for sustained specific release of an amount effective to suppress appetite when administered orally to an individual are disclosed. Compositions comprising a guanylyl cyclase C agonist formulated for intravenous delivery in an amount effective to suppress appetite when administered intravenously to an individual are also disclosed. Methods of suppressing appetite in an individual are disclosed. | 2012-03-15 |
20120064040 | SERUM FREE CULTURE MEDIUM AND SUPPLEMENT - Provided herein is a chemically defined method of endothelial cell (EC) derivation from embryonic stem cells (ESC). These progenitor cells are capable of low-density lipoprotein uptake, an important function of EC, and also express EC specific markers. By using chemically defined culture conditions, the reproducibility of the derivation as well as eliminate the possibility of unknown contaminants such as undefined growth factors and sundry animal proteins is improved. The differentiated cells can then be applied to a myriad of potential therapies such as tissue engineered vascular grafts, cardiac patches, and pre-vascularized tissue transplants. | 2012-03-15 |
20120064041 | Efficient Generation of Neurally-Induced Mesenchymal Stem Cells and Applications Thereof - The present invention provides methods and compositions for reprogramming mammalian mesenchymal stem cells, as well as to methods for using such cells, for example, to prevent or treat various injuries, diseases, and disorders in human and non-human animals. | 2012-03-15 |
20120064042 | XENO-FREE GENERATION OF TISSUE-SPECIFIC PROGENITOR CELLS - The invention relates to purified, tissue-specific progenitors, methods of making and using such tissue-specific progenitors. | 2012-03-15 |
20120064043 | TISSUE ENGINEERING SCAFFOLDS AND METHODS OF USE - Provided herein are methods of producing a meniscus scaffold to remove material and increase the pore size and porosity therein. In some embodiments, methods include seeding the tissue with allogeneic or autogeneic cells. Bioscaffolds produced by the processes described herein are also provided, as are methods of treating a subject in need of a bioscaffold implant. | 2012-03-15 |
20120064044 | METHODS OF TREATING EDEMA RELATED TO ISCHEMIA-REPERFUSION - Methods are described for preventing or reducing edema related to ischemia-reperfusion by treating the organ or tissue being transplanted with an aminoalkyl glucosaminide phosphate. | 2012-03-15 |
20120064045 | COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE MYOCARDIAL INJURY DUE TO A VASCULAR INSUFFICIENCY - The described invention provides methods and regimens for treating adverse consequences of a persistent and progressive myocardial injury-due to a vascular insufficiency that occurs early or late in a subject in need thereof, and progressive myocardial injury-preventing compositions that contain a chemotactic hematopoietic stem cell product, and, optionally, an additional active agent. | 2012-03-15 |
20120064046 | MAINTENANCE AND PROPAGATION OF MESENCHYMAL STEM CELLS - Various embodiments of the present invention include compositions, materials and methods for maintaining and propagating mammalian mesenchymal stem cells in an undifferentiated state in the absence of feeder cells and applications of the same. | 2012-03-15 |
20120064047 | Use of Multipotent Adult Stem Cells in Treatment of Myocardial Infarction and Congestive Heart Failure - The invention provides isolated stem cells of non-embryonic origin that can be maintained in culture in the undifferentiated state or differentiated to form cells of multiple tissue types. Also provided are methods of isolation and culture, as well as therapeutic uses for the isolated cells in cardiac indications. | 2012-03-15 |
20120064048 | TREATMENT OF REPROGRAMMING FACTOR RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO A REPROGRAMMING FACTOR - The present invention relates to antisense oligonucleotides that modulate the expression of and/or function of a Reprogramming factor, in particular, by targeting natural antisense polynucleotides of a Reprogramming factor. The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of Reprogramming factors. | 2012-03-15 |
20120064049 | USE OF STEM CELLS FROM HAIR ROOT SHEATHS AND KERATINOCYTE PRECURSOR CELLS FOR THE REGENERATION OF AGED SKIN - The present invention relates to the use of stem cells from hair root sheaths and/or keratinocyte precursor cells for the regeneration of aged but otherwise healthy and non-injured skin for the cosmetic purposes and for the prevention of skin diseases. In addition, the invention is directed to a cosmetic method for the regeneration of aged skin. | 2012-03-15 |
20120064050 | Tissue Engineering of Lung - The present invention relates to compositions comprising a decellularized tissue. The present invention also provides an engineered three dimensional lung tissue exhibiting characteristics of a natural lung tissue. The engineered tissue is useful for the study of lung developmental biology and pathology as well as drug discovery. | 2012-03-15 |
20120064051 | INFANT AND YOUNG CHILDREN FEEDING FORMULA COMPRISING PROBIOTICS FOR INFANTS AND YOUNG CHILDREN - The present invention relates to the field of infant and young children nutrition. In particular, the present invention relates to infant and young children feeding formulas comprising probiotic micro-organisms to be administered to infants and young children older than 6 months. These probiotic micro-organisms may be non-replicating probiotic micro-organisms such as bioactive heat treated probiotic micro-organisms, for example. | 2012-03-15 |
20120064052 | Hydrolysis Resistant Organomodified Trisiloxane Surfactants - Three types of trisiloxane surfactants having the basic formula: | 2012-03-15 |